Home LiteratureArticle Details
PMID: 8676450 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.

Journal of virology ·Vol. 70 ·No. 7 ·1996-07-00 ·Pages 4283-90

Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC

Abstract

Type 1 human immunodeficiency viruses encoding mutated nef reading frames are 10- to 30-fold less infectious than are isogenic viruses in which the nef gene is intact. This defect in infectivity causes nef-negative viruses to grow at an attenuated rate in vitro. To investigate the mechanism of Nef-mediated enhancement of viral growth rate and infectivity, a complementation analysis of nef mutant viruses was performed. To provide Nef in trans upon viral infection, a CEM derivative cell line (designated CLN) that expresses Nef under the control of the viral long terminal repeat was constructed. When nef-negative virus was grown in CLN cells, its growth rate was restored to wild-type levels. However, the output of nef-negative virus during the first 72 h after infection of CLN cells was not restored, suggesting that provision of Nef within the newly infected cell does not enhance the productivity of a nef-negative provirus. The genetically nef-negative virions produced by the CLN cells, however, were restored to wild-type levels of infectivity as measured in a syncytium formation assay in which CD4-expressing HeLa cells were targets. These trans-complemented, genetically nef-negative virions yielded wild-type levels of viral output following a single cycle of replication in primary CD4 T cells as well as in parental CEM cells. To define the determinants for producer cell modification of virions by Nef, the role of myristoylation was investigated. Virus that encodes a myristoylation-negative nef was as impaired in infectivity as was virus encoding a deleted nef gene. Because myristoylation is required for both membrane association of Nef and optimal viral infectivity, the possibility that Nef protein is included in the virion was investigated. Wild-type virions were purified by filtration and exclusion chromatography. A Western blot (immunoblot) of the eluate fractions revealed a correlation between peak Nef signal and peak levels of p24 antigen. Although virion-associated Nef was detected in part as the 27-kDa full-length protein, the majority of immunoreactive protein was detected as a 20-kDa isoform. nef-negative virus lacked both 27- and 20-kDa immunoreactive species. Production of wild-type virions in the presence of a specific inhibitor of the human immunodeficiency virus type 1 protease resulted in virions which contained only 27-kDa full-length Nef protein. These data indicate that Nef is a virion protein which is processed by the viral protease into a 20-kDa isoform within the virion particle.

MeSH Terms
CD4-Positive T-Lymphocytes/metabolism,virology Cell Line Gene Products, nef/genetics,metabolism,physiology Genetic Complementation Test HIV Core Protein p24/metabolism HIV Protease/metabolism HIV-1/genetics,pathogenicity,physiology Mutation Myristic Acid Myristic Acids/metabolism Recombinant Proteins/genetics,pharmacology Tumor Cells, Cultured Virion/physiology nef Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, nef HIV Core Protein p24 Myristic Acids Recombinant Proteins nef Gene Products, Human Immunodeficiency Virus Myristic Acid HIV Protease
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Pandori M W
Department of Medicine, University of California San Diego School of Medicine, California 92093-0619, USA.
Fitch N J
Craig H M
Richman D D
Spina C A
Guatelli J C
References (33)
33 references, click to expand
  1. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
    J Virol. 1991 Feb;65(2):852-60 PMID: 1898972
  2. Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells.
    J Virol. 1991 Feb;65(2):583-8 PMID: 1987371
  3. Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
    Cell. 1991 May 17;65(4):651-62 PMID: 2032289
  4. Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes.
    Virology. 1992 May;188(1):391-5 PMID: 1566581
  5. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene.
    EMBO J. 1993 Feb;12(2):703-13 PMID: 8095017
  6. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.
    J Exp Med. 1993 Jun 1;177(6):1561-6 PMID: 8098729
  7. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.
    J Virol. 1993 Aug;67(8):4639-50 PMID: 8043040
  8. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
    J Exp Med. 1994 Jan 1;179(1):101-13 PMID: 8270859
  9. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.
    J Exp Med. 1994 Jan 1;179(1):115-23 PMID: 7903679
  10. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain.
    Cell. 1994 Mar 11;76(5):853-64 PMID: 8124721
  11. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.
    J Virol. 1994 May;68(5):2906-14 PMID: 8151761
  12. Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1.
    Eur J Biochem. 1994 Apr 15;221(2):811-9 PMID: 8174561
  13. HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement.
    J Immunol. 1994 May 15;152(10):5128-34 PMID: 8176229
  14. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease.
    Eur J Biochem. 1994 Jul 15;223(2):589-93 PMID: 8055930
  15. The role of Nef in the replication cycle of the human and simian immunodeficiency viruses.
    Virology. 1994 Nov 15;205(1):1-6 PMID: 7975204
  16. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1.
    Virology. 1994 Dec;205(2):578-82 PMID: 7975260
  17. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry.
    J Virol. 1995 Jan;69(1):579-84 PMID: 7983759
  18. Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease.
    FEBS Lett. 1995 Jan 9;357(3):275-8 PMID: 7835426
  19. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.
    EMBO J. 1995 Feb 1;14(3):484-91 PMID: 7859737
  20. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization.
    Immunity. 1994 Aug;1(5):373-84 PMID: 7882168
  21. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell.
    J Virol. 1995 Jul;69(7):4053-9 PMID: 7539505
  22. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.
    J Virol. 1995 Jul;69(7):4112-21 PMID: 7769669
  23. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity.
    J Biol Chem. 1995 Jun 23;270(25):15307-14 PMID: 7797518
  24. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    J Virol. 1995 Aug;69(8):5048-56 PMID: 7541845
  25. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys.
    Cell. 1995 Aug 25;82(4):665-74 PMID: 7664345
  26. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.
    Virology. 1995 Oct 1;212(2):451-7 PMID: 7571414
  27. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
    Science. 1995 Nov 10;270(5238):988-91 PMID: 7481804
  28. SC-52151, a novel inhibitor of the human immunodeficiency virus protease.
    Antimicrob Agents Chemother. 1995 Oct;39(10):2229-34 PMID: 8619573
  29. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product.
    Nature. 1987 Nov 19-25;330(6145):266-9 PMID: 3118220
  30. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity.
    J Virol. 1988 Oct;62(10):3779-88 PMID: 3047430
  31. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9544-8 PMID: 2687883
  32. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.
    J Exp Med. 1990 Oct 1;172(4):1035-42 PMID: 2212939
  33. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.
    Nature. 1991 Apr 11;350(6318):508-11 PMID: 2014052
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-07-00
Pages
4283-90
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC190360
Subset
IM
Grants
NIAID NIH HHS · AI27670 · United States
NIAID NIH HHS · AI29164 · United States
NIAID NIH HHS · AI30457 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]